AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹14,682 Cr | ₹12,199 Cr | ₹11,494 Cr | ₹8,156 Cr | ₹10,665 Cr |
What is the latest Total Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹14,682 Cr |
| Mar2024 | ₹12,199 Cr |
| Mar2023 | ₹11,494 Cr |
| Mar2022 | ₹8,156 Cr |
| Mar2021 | ₹10,665 Cr |
How is Total Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,682 Cr | 20.36 | |
| Mar2024 | ₹12,199 Cr | 6.14 | |
| Mar2023 | ₹11,494 Cr | 40.92 | |
| Mar2022 | ₹8,156 Cr | -23.53 | |
| Mar2021 | ₹10,665 Cr | - | |
Compare Total Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,131.6 Cr | -3.7% | 8.7% | -3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -3.7% |
8.7% |
-3.4% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses